A Study on the Properties of Composite Modified Mortar with Styrene-Butadiene Rubber Latex and Silica Fume.

To solve the problem of the poor abrasion resistance of concrete pavement surface mortar, this study substituted cement with equal amounts of styrene-butadiene rubber (SBR) latex and silica fume (SF) to investigate the effects of organic/inorganic material composite modification on the fluidity, drying shrinkage, mechanical properties, and abrasion resistance of cement mortar. Also in this study, the microstructure, product, and pore structure characteristics of the composite modified cement mortar were investigated using scanning electron microscope (SEM), X-Ray diffraction (XRD), Fourier-transform infrared spectroscopy (FT-IR), and the Brunauer-Emmett-Teller (BET) method. This research found that the sole substitution of SF negatively impacted the mortar's fluidity and drying shrinkage yet enhanced its mechanical strength and abrasion resistance; the incorporation of SBR latex improved fluidity, reduced shrinkage, and increased flexural strength but adversely affected the compressive strength of the mortar.

Synergistic Effects from Combination of Cryptotanshinone and Fosfomycin Against Fosfomycin-Susceptible and Fosfomycin-Resistant .

Purpose: Fosfomycin is now widely used to treat methicillin-resistant due to its unique antibacterial activity. However, fosfomycin-resistant has rapidly emerged, it is urgent to find new treatments to eliminate fosfomycin-resistant infection. The purpose of this study was to analyze the activity of cryptanshinone, a traditional Chinese medicine monomer, in combination with fosfomycin against fosfomycin-sensitive (FSSA) and fosfomycin-resistant (FRSA).

SARS-CoV-2 and SARS-CoV: Virtual screening of potential inhibitors targeting RNA-dependent RNA polymerase activity (NSP12).

Since the outbreak of severe acute respiratory syndrome (SARS) in 2003, the harm caused by coronaviruses to the world cannot be underestimated. Recently, a novel coronavirus (severe acute respiratory syndrome coronavirus-2 [SARS-CoV-2]) initially found to trigger human severe respiratory illness in Wuhan City of China in 2019, has infected more than six million people worldwide by 21 June 2020, and which has been recognized as a public health emergency of international concern as well. And the virus has spread to more than 200 countries around the world.